Quarterly report pursuant to Section 13 or 15(d)

Contingencies (Details Narrative 3)

v2.4.0.6
Contingencies (Details Narrative 3) (USD $)
 6 Months Ended
Jun. 30, 2012
Litigation filed by Aphena Pharma Solutions – Maryland, LLC f/k/a Celeste Contract Packaging, LLC
  
Loss Contingencies [Line Items]  
Name of Plaintiff Aphena Pharma Solutions – Maryland, LLC f/k/a Celeste Contract Packaging, LLC
Name of Defendant BioZone Laboratories, Inc. and BioZone Pharmaceuticals, Inc. and Daniel Fisher
Domicile of Litigation DISTRICT COURT FOR THE DISTRICT OF MARYLAND NORTHERN DIVISION
Case Number Case 1:12-cv-00852-WDQ
Lawsuit Filing Date 19-Mar-12
Allegations Alleges breach of contract and other commercial wrongdoing in connection with a single purchase order issued during early 2010 relating to the development of certain over the counter products to treat cough and cold symptoms.
Damages Sought Although the complaint does not specify the amount of plaintiff’s alleged monetary damages, plaintiff’s payment associated with the purchase order was less than $190,000.
Litigation filed by Daniel Fisher
  
Loss Contingencies [Line Items]  
Name of Plaintiff Daniel Fisher
Name of Defendant BiZone Pharmaceuticals, Inc., Elliot Maza, Brauser Honig Frost Group, Michael Brauser, Barry Honig, and The Frost Group LLC
Domicile of Litigation United States District Court, Northern District of California
Case Number No. 12-03716
Lawsuit Filing Date 16-Jul-12
Allegations

Fisher asserts claims for breach of contract, conversion, wrongful termination, and unjust enrichment, and violation of the federal whistleblower statute arising from his former role as an officer and director of the Company and certain contractual agreements that he entered into with the Company.
Damages Sought, Value 23,000,000
Actions Taken by Defendant The Company disputes Fisher’s allegations, intends to vigorously defend them, and has filed an action against Fisher in New York.
Litigation filed by BioZone Pharmaceuticals, Inc
  
Loss Contingencies [Line Items]  
Name of Plaintiff BioZone Pharmaceuticals, Inc
Name of Defendant Daniel Fisher and 580 Garcia Properties, LLC
Domicile of Litigation Supreme Court of the State of New York, County of New York
Case Number No. 652489/2012
Lawsuit Filing Date 18-Jul-12
Allegations Alleging breach of contract, breach of fiduciary duty, negligence, and fraud claims arising from Fisher’s former role as an officer and director of the company
Damages Sought The Company is seeking $2 million in damages, together with the cancellation of 6.65 million shares of the Company’s stock, and Fisher’s forfeiture of property located at 580 Garcia Avenue, Pittsburg, CA, which property is used by the Company as a warehouse facility.